Quest Diagnostics (DGX) Short-term Investments (2010 - 2011)

Quest Diagnostics' (DGX) quarterly Short-term Investments came in at $56.5 million in Q4 2011, up 439.16% year-on-year from $10.5 million in Q4 2010, and up 4.03% quarter-over-quarter from $54.3 million in Q3 2011.

Quest Diagnostics (DGX) Short-term Investments (2010 - 2011) Analysis & Trends

Quest Diagnostics has disclosed Short-term Investments across 2 years of filings, most recently posting $56.5 million for Q4 2011.

  • Short-term Investments for Q4 2011 came in at $56.5 million, up 439.16% year-over-year; the trailing twelve-month figure through Dec 2011 was $56.5 million (up 439.16% YoY), and the FY2011 annual result was $56.5 million, up 439.16% from the prior year.
  • Short-term Investments came in at $56.5 million for Q4 2011 at Quest Diagnostics, up from $54.3 million in the prior quarter.
  • In the past five years, Short-term Investments ranged from a high of $56.5 million in Q4 2011 to a low of $10.5 million in Q4 2010.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Waters 30,529.42 Bn 30,528.96 Bn 1.11 Bn
2 Thermo Fisher Scientific 183.75 Bn 180.50 Bn 7.74 Bn
3 Danaher 133.13 Bn 127.43 Bn 3.59 Bn
4 Idexx Laboratories 46.14 Bn 45.94 Bn 722.74 Mn
5 Agilent Technologies 38.20 Bn 36.39 Bn 990.00 Mn
6 Natera 31.50 Bn 30.40 Bn 696.04 Mn
7 Iqvia Holdings 31.34 Bn 29.36 Bn 1.36 Bn
8 Illumina 24.51 Bn 23.36 Bn 721.00 Mn
9 Mettler Toledo International 23.53 Bn 23.47 Bn 555.82 Mn
10 Quest Diagnostics 22.51 Bn 22.42 Bn 942.00 Mn

Historic Data

Download Data
DateValue
Dec 31, 2011 56.52 Mn
Sep 30, 2011 54.33 Mn
Jun 30, 2011 18.94 Mn
Dec 31, 2010 10.48 Mn